Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-08-04

Clinical Trial Update: A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating testosterone treatment for men with multiple sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Multiple Sclerosis | Phase 2 | Status: WITHDRAWN